Article
Emerging Trends and Opportunities in Orally Inhaled Drug Products
Summary: In this Q&A article, sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úexperts Carolyn Berg and Carla Vozone discuss innovations in orally inhaled drug products, in particular dry powders for inhalation.
View Now
Webinars
Intranasal Drug Delivery-Identifying Challenges and New Product Opportunities
Intranasal delivery is emerging as an alternative route of systemic drug delivery for a variety of indications such as migraine, seizures, breakthrough pain and opioid overdose and more.
View Now
Article
HPAPI Development and Manufacturing Using Micronization Technology
Summary: Download this executive summary to learn more about safe and successful HPAPI product development and manufacturing using micronization.
View Now
Article
Concept to Dosing: Challenges in New Orphan Drugs
Summary: As drug developers look to address unmet medical needs for orphan diseases, working with experienced partners can help in navigating key challenges such as a limited active pharmaceutical ingredient supply, efficient small-scale manufacturing for small patient populations and distribution logistics
View Now
Video
Parallel Screening for Oral Delivery of Macromolecules
Summary: To rapidly screen macromolecules’ potential for oral delivery, it is critical to assess multiple enabling technologies in parallel, targeting different biological barriers.
View Now
Webinars
Navigating your Biopharma Drug Candidate Through Early and Mid-Stage Clinical Trials
Summary: Decisions made throughout early and mid-stage clinical trials impact late-stage results and sometimes, entire programs and companies. Since some obstacles can prove overwhelming for startups, there is a lot to learn from those who successfully walked the path.
View Now
Webinars
Executive Interview with sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿ÚPresident and COO at Fierce JPM Week 2022
Summary: During Fierce JPM Week 2022, Catalent’s President and COO Alessandro Maselli sat down and discussed how the pandemic changed the pharmaceutical landscape and how CDMOs...
View Now
Webinars
Dosage Form Design and Patient Compliance-Exploring ODTs as a Patient-centric Solution
Summary: In this webinar, experts provide an overview of the needs of different patient populations and examine the common challenges leading to non-compliance.
View Now
Webinars
Our Predictions for the 2022 Pharma Industry
Summary: Catalent’s CEO John Chiminski and Endpoints News’ John Carroll have a virtual fireside chat discussing their predictions for what 2022 has in store for the biopharma industry.
View Now
Case Study
Leveraging Catalent's Integrated Network to Accelerate Spray Drying and Tableting Scale-Up
Learn how a biopharmaceutical company partnered with sa¹ú¼Ê´«Ã½¹ÙÍøÍøÒ³Èë¿Úto develop and manufacture a commercially-viable, patient-friendly, stable tablet for a program intended to treat a disease that has unmet medical need.
View Now
